Search in this site

Grenoble Excellence in neurodegeneration Grenoble Excellence in neurodegeneration

Home > About GREEN > Presentation

See the complete sitemap

Presentation of GREEN

GREnoble Excellence in Neurodegeneration, “GREEN”, is supported by the University of Grenoble Alpes (UGA). In our university health and technologies are one of the four main socio-economic challenges of the Grenoble IDEX. It is associated with the University Hospital of Grenoble (CHUGA).

The strategic choice of GREEN is to promote synergies between the research teams of Grenoble working in the field of neurodegenerative disorders in an organized community, mainly around Alzheimer’s disease (AD), Parkinson’s disease (PD), Multiple Sclerosis (MS) and Huntington’s disease (HD)). This is made possible by the existence of a multidisciplinarity based on strong fundamental, clinical and social sciences researches, as well as on the development of innovative technologies.

GREEN partners include the research teams, companies, the actors of the associative sectors and all the health professionals having an activity on neurodegenerative disorders are “partner” of GREEN.

Teams partners of GREEN belong to:

Local and national partners of GREEN

GREEN also collaborates with the MINATEC technology campus and innovative biotechnological platforms, EMBL, Institute of Structural Biology (IBS), University Hospital (CHUG), BIOPOLIS as well as Lyon Biopole and Minalogic (2 competitive poles)  and is in close contact with local and national companies (Synapcell, PiXyl, etc.).



International and national networks

GREEN teams belong to international and national networks of excellence in complementary disciplinary fields. These networks encompass high level research teams whose excellence is recognized in each of their specific domains

  • NeuroPsyNov: University Hospital Federation (FHU) for refractory neuropsychiatric disorders

  • GRECO: group recognized for the Excellence in Cognitive research,

  • French Center of Excellence for Parkinson’s Disease,

  • The USA Parkinson Study Group (PSG)

  • BrainTeam, network of rare diseases of nervous system

Updated on March 16, 2023

Associés renforcés
Associés simples